Jingjing Zhao1, Fang Yuan1, Feng Fu2, Yi Liu3, Changhu Xue4, Kangjun Wang5, Xiangjun Yuan6, Dingan Li5, Qiuwu Liu7, Wei Zhang8, Yi Jia9, Jianbo He10, Jun Zhou11, Xiaocheng Wang12, Hua Lv13, Kang Huo14, Zhuanhui Li15, Bei Zhang16, Chengkai Wang17, Xiaomu Wang1, Hongzeng Li8, Fang Yang1,18, Wen Jiang1,18. 1. Department of Neurology, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China. 2. Department of Neurology, 215 Hospital of Shaanxi NI, Xianyang, 712021, China. 3. Department of Neurology, Ankang Central Hospital, Ankang, 725000, China. 4. Department of Neurology, Xianyang Central Hospital, Xianyang, 712000, China. 5. Department of Neurology, Hanzhong Central Hospital, Hanzhong, 723000, China. 6. Department of Neurology, Weinan Central Hospital, Weinan, 714000, China. 7. Department of Neurology, Xi'an 141 Hospital, Xi'an, 710499, China. 8. Department of Neurology, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038, China. 9. Department of Neurology, Xi'an Gaoxin Hospital, Xi'an, 710075, China. 10. Department of Neurology, Xi'an XD Group Hospital, Xi'an, 710077, China. 11. Department of Neurology, Shangluo Central Hospital, Shangluo, 726000, China. 12. Department of Neurology, Yulin No.2 Central Hospital, Yulin, 719000, China. 13. Department of Neurology, Shaanxi Provincial People's Hospital, Xi'an, 710068, China. 14. Department of Neurology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China. 15. Department of Neurology, 521 Hospital of NORINCO Group, Xi'an, 710000, China. 16. Department of Neurology, The First Affiliated Hospital of Xi'an Medical University, Xi'an, 710021, China. 17. Department of Neurology, Tongchuan People's Hospital, Tongchuan, China. 18. The Shaanxi Cerebrovascular Disease Clinical Research Center, Xi'an, 710032, China.
Abstract
OBJECTIVE: To explore the effect of individualized blood pressure (BP)-lowering treatment on the outcomes of elderly patients with severe intracerebral hemorrhage (ICH). METHODS: We performed an exploratory analysis of Controlling Hypertension After Severe Cerebrovascular Event (CHASE) trial, which was a multicenter, randomized, controlled clinical trial. Patients with severe ischemic or hemorrhagic stroke (defined as GCS ≤ 12 or NIHSS ≥ 11) were randomized into individualized versus standard BP-lowering treatment in CHASE trial. In this exploratory analysis, patients with severe ICH were included. The primary outcome was the percentage of patients with 90-day functional independence defined as modified Rankin Scale (mRS) ≤2. RESULTS: We included 242 patients with severe ICH in the present analysis, consisting of 142 patients aged <65 years and 100 patients aged ≥65 years. There were significant differences between patients aged ≥65 years and <65 years in the proportion of functional independence (47.9% vs. 15.0%, P < 0.001) and good outcome (73.9% vs. 50.0%, P < 0.001) at day 90. In patients aged ≥65 years, the adjusted individualized BP-lowering treatment had an unequivocal effect on the functional independence at day 90 (21.6% vs. 8.2%, odds ratio [OR]: 4.309, 95% confidence interval [CI]: 1.040-17.859, P = 0.044) and improved the neurological deficits at discharge (∆ NIHSS ≥ 4: 64.7% vs. 34.7%, OR: 4.300, 95% CI: 1.599-11.563, P = 0.004). INTERPRETATION: Compared with the younger counterparts, the elderly patients (≥65 years) with acute severe ICH might benefit more from individualized BP-lowering treatment.
OBJECTIVE: To explore the effect of individualized blood pressure (BP)-lowering treatment on the outcomes of elderly patients with severe intracerebral hemorrhage (ICH). METHODS: We performed an exploratory analysis of Controlling Hypertension After Severe Cerebrovascular Event (CHASE) trial, which was a multicenter, randomized, controlled clinical trial. Patients with severe ischemic or hemorrhagic stroke (defined as GCS ≤ 12 or NIHSS ≥ 11) were randomized into individualized versus standard BP-lowering treatment in CHASE trial. In this exploratory analysis, patients with severe ICH were included. The primary outcome was the percentage of patients with 90-day functional independence defined as modified Rankin Scale (mRS) ≤2. RESULTS: We included 242 patients with severe ICH in the present analysis, consisting of 142 patients aged <65 years and 100 patients aged ≥65 years. There were significant differences between patients aged ≥65 years and <65 years in the proportion of functional independence (47.9% vs. 15.0%, P < 0.001) and good outcome (73.9% vs. 50.0%, P < 0.001) at day 90. In patients aged ≥65 years, the adjusted individualized BP-lowering treatment had an unequivocal effect on the functional independence at day 90 (21.6% vs. 8.2%, odds ratio [OR]: 4.309, 95% confidence interval [CI]: 1.040-17.859, P = 0.044) and improved the neurological deficits at discharge (∆ NIHSS ≥ 4: 64.7% vs. 34.7%, OR: 4.300, 95% CI: 1.599-11.563, P = 0.004). INTERPRETATION: Compared with the younger counterparts, the elderly patients (≥65 years) with acute severe ICH might benefit more from individualized BP-lowering treatment.
Authors: Adnan I Qureshi; Yuko Y Palesch; William G Barsan; Daniel F Hanley; Chung Y Hsu; Renee L Martin; Claudia S Moy; Robert Silbergleit; Thorsten Steiner; Jose I Suarez; Kazunori Toyoda; Yongjun Wang; Haruko Yamamoto; Byung-Woo Yoon Journal: N Engl J Med Date: 2016-06-08 Impact factor: 91.245
Authors: Tom J Moullaali; Xia Wang; Reneé H Martin; Virginia B Shipes; Thompson G Robinson; John Chalmers; Jose I Suarez; Adnan I Qureshi; Yuko Y Palesch; Craig S Anderson Journal: Lancet Neurol Date: 2019-09 Impact factor: 44.182
Authors: J Claude Hemphill; Steven M Greenberg; Craig S Anderson; Kyra Becker; Bernard R Bendok; Mary Cushman; Gordon L Fung; Joshua N Goldstein; R Loch Macdonald; Pamela H Mitchell; Phillip A Scott; Magdy H Selim; Daniel Woo Journal: Stroke Date: 2015-05-28 Impact factor: 7.914
Authors: Charlotte Jj van Asch; Merel Ja Luitse; Gabriël Je Rinkel; Ingeborg van der Tweel; Ale Algra; Catharina Jm Klijn Journal: Lancet Neurol Date: 2010-01-05 Impact factor: 44.182
Authors: Craig S Anderson; Emma Heeley; Yining Huang; Jiguang Wang; Christian Stapf; Candice Delcourt; Richard Lindley; Thompson Robinson; Pablo Lavados; Bruce Neal; Jun Hata; Hisatomi Arima; Mark Parsons; Yuechun Li; Jinchao Wang; Stephane Heritier; Qiang Li; Mark Woodward; R John Simes; Stephen M Davis; John Chalmers Journal: N Engl J Med Date: 2013-05-29 Impact factor: 91.245